Shares rose 6.3% following Q2 results as revenue growth of 12.5% and adjusted EBITDA growth of 16.9% both came in ahead of expectations, supported by strong traction in the career networks segment and increased full-year guidance.
- Revenue reached a record $83.7 million, up 12.5% year-over-year.
- Adjusted EBITDA increased 16.9% to $20.6 million, with operating income up 41.4% year-over-year.
- Management raised full-year revenue and adjusted EBITDA guidance based on strong first-half results.
- Career networks, particularly myClinicalExchange, expanded 29% YoY, driven by investments including 15 new positions added beyond initial budgets.
- Company highlighted a strong balance sheet with $66.7 million cash, no long-term debt, and available line of credit, supporting M&A and strategic investments.
Community Discussion